The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Impact of Antibiotics on Expression of Virulence‐Associated Exotoxin Genes in Methicillin‐Sensitive and Methicillin‐Resistant Staphylococcus aureus
Abstract
Extracellular protein toxins contribute to the pathogenesis of a wide variety of Staphylococcus aureus infections. The present study investigated the effects that cell-wall active antibiotics and protein-synthesis inhibitors have on transcription and translation of genes for Panton-Valentine leukocidin, alpha-hemolysin, and toxic-shock syndrome toxin 1, in both methicillin-sensitive and methicillin-resistant S. aureus. Subinhibitory concentrations of nafcillin induced and prolonged mRNA for Panton-Valentine leukocidin, alpha-toxin, and toxic-shock syndrome toxin 1 and increased toxin production. In contrast, clindamycin and linezolid markedly suppressed translation, but not transcription, of toxin genes. These results suggest (1) that protein-synthesis inhibition is an important consideration in the selection of antimicrobial agents to treat serious infections caused by toxin-producing gram-positive pathogens and (2) that, by inducing and enhancing toxin production, inadvertent use of beta-lactam antibiotics to treat methicillin-resistant S. aureus infections may contribute to worse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 1×
“PVL causes tissue necrosis in experimental animals [33] and has been implicated, at least epidemiologically, in severe infections in humans, such as necrotizing fasciitis and necrotizing pneumonia [7, 8, 19, 34]; at present, however, no data exist that define a role for PVL in the pathogenesis of CA-MRSA infections.”
BackgroundCosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053 · cited 1×
“PVL causes tissue necrosis in experimental animals [33] and has been implicated, at least epidemiologically, in severe infections in humans, such as necrotizing fasciitis and necrotizing pneumonia [7, 8, 19, 34]; at present, however, no data exist that define a role for PVL in the pathogenesis of CA-MRSA infections.”
BackgroundDissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community
Okuma, K., Iwakawa, K., Turnidge, J. D., Grubb, W. B., Bell, J. M., O'Brien, F. G., Coombs, G. W., Pearman, J. W., Tenover, F. C., Kapi, M., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4289-4294.2002 · Cited by 888
Francis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Schlievert, P. M., Shands, K. N., Dan, B. B., Schmid, G. P., & Nishimura, R. D. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.4.509 · Cited by 665
Ma, X. X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., Daum, R. S., & Hiramatsu, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1147-1152.2002 · Cited by 587
Stevens, D. L., Gibbons, A. E., Bergstrom, R., & Winn, V. (1988) · Journal of Infectious Diseases · doi:10.1093/infdis/158.1.23 · Cited by 473
Self-citationKANEKO, J., & KAMIO, Y. (2004) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.68.981 · Cited by 339
ZIMBELMAN, J., PALMER, A., & TODD, J. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199912000-00014 · Cited by 322
Kollef, M. H., Rello, J., Cammarata, S. K., Croos-Dabrera, R. V., & Wunderink, R. G. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2088-1 · Cited by 315
Daum, R. S., Ito, T., Hiramatsu, K., Hussain, F., Mongkolrattanothai, K., Jamklang, M., & Boyle‐Vavra, S. (2002) · The Journal of Infectious Diseases · doi:10.1086/344326 · Cited by 295
Experimental approach to the problem of treatment failure with penicillin
Eagle, H. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90293-3 · Cited by 280
Diep, B. A., Sensabaugh, G. F., Somboona, N. S., Carleton, H. A., & Perdreau-Remington, F. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2080-2084.2004 · Cited by 257
Mongkolrattanothai, K., Boyle, S., Kahana, M. D., & Daum, R. S. (2003) · Clinical Infectious Diseases · doi:10.1086/378277 · Cited by 230
Stevens, D. L., Van, S., & Bryant, A. E. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1401 · Cited by 211 · cited 2×
“For both strains, nafcillin concentrations 2 mg/mL resulted in reduced alpha-hemolysin production (figure 4B), despite prolonged mRNA expression at these concentrations, which suggests that saturation of the presumed target PBPs play an as-yet-undefined role in either synthesis regulation or toxin release from the cel…”
BackgroundSelf-citationSubinhibitory Concentrations of Linezolid Reduce Staphylococcus aureus Virulence Factor Expression
Bernardo, K., Pakulat, N., Fleer, S., Schnaith, A., Utermöhlen, O., Krut, O., Müller, S., & Krönke, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.546-555.2004 · Cited by 211
Ohlsen, K., Ziebuhr, W., Koller, K.-P., Hell, W., Wichelhaus, T. A., & Hacker, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2817 · Cited by 210
Buckingham, S. C., McDougal, L. K., Cathey, L. D., Comeaux, K., Craig, A. S., Fridkin, S. K., & Tenover, F. C. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000131981.67342.c4 · Cited by 181
Effect of antibiotics on toxin production and viability of Clostridium perfringens
Stevens, D. L., Maier, K. A., & Mitten, J. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.213 · Cited by 171
Self-citationClindamycin-Induced Suppression of Toxic-Shock Syndrome-Associated Exotoxin Production
Schlievert, P. M., & Kelly, J. A. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.3.471 · Cited by 162
Stevens, D. L., Maier, K. A., Laine, B. M., & Mitten, J. E. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.2.220 · Cited by 137
Self-citationGemmell, C. G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf192 · Cited by 120
Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin
Ward, P. D., & Turner, W. H. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.393-397.1980 · Cited by 108
Stevens, D. L. (1996) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70324-x · Cited by 104
Self-citation[6] Preparation of toxic shock syndrome toxin-1
Blomster-Hautamaa, D. A., & Schlievert, P. M. (1988) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(88)65009-9 · Cited by 97
Stevens, D. L., Wallace, R. J., Hamilton, S. M., & Bryant, A. E. (2006) · Clinical Infectious Diseases · doi:10.1086/500265 · Cited by 74
Self-citationTransatlantic Spread of the USA300 Clone of MRSA
Tietz, A., Frei, R., & Widmer, A. F. (2005) · New England Journal of Medicine · doi:10.1056/nejm200508043530522 · Cited by 53
van Langevelde, P., van Dissel, J. T., Meurs, C. J. C., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1682 · Cited by 43
Effect of sub‐inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus
Doss, S. A., Tillotson, G., & Amyes, S. G. B. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb02756.x · Cited by 32
Methicillin-resistant Staphylococcus aureus Toxic Shock Syndrome
Jamart, S., Denis, O., Deplano, A., Tragas, G., Vandergheynst, A., Bels, D. D., & Devriendt, J. (2005) · Emerging infectious diseases · doi:10.3201/eid1104.040893 · Cited by 31
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Taxonomy, Physiology, and Natural Products of Actinobacteria
Barka, E. A., Vatsa, P., Sanchez, L., Gaveau-Vaillant, N., Jacquard, C., Klenk, H.-P., Clément, C., Ouhdouch, Y., & van Wezel, G. P. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00019-15 · Cited by 2,188
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
Antibiotic efficacy is linked to bacterial cellular respiration
Lobritz, M. A., Belenky, P., Porter, C. B. M., Gutierrez, A., Yang, J. H., Schwarz, E. G., Dwyer, D. J., Khalil, A. S., & Collins, J. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509743112 · Cited by 773
Metadata
- Authors
- Stevens, D. L., Ma, Y., Salmi, D. B., McIndoo, E., Wallace, R. J., & Bryant, A. E.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-15
- Volume
- 195
- Issue
- 2
- Pages
- 202-211
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2162000793
- Cited by
- 452
- References
- 34
- FWCI
- 18.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.